ClinicalTrials.Veeva

Menu

Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism. (PADIS-HTP)

R

Regional University Hospital Center (CHRU)

Status

Terminated

Conditions

HTPPE
Idiopathic Pulmonary Embolism

Treatments

Other: HTPPE

Study type

Interventional

Funder types

Other

Identifiers

NCT01894204
RB 12.161 - PADIS HTP

Details and patient eligibility

About

Forward-looking troop established(constituted) by the patients having been included in the study " PADIS EP ", PHRC on 2006 and 2009, randomized checked(controlled), double-blind, comparing an anticoagulating treatment(processing) extended by coumadine versus placebo during 18 months at patients having had a first episode of EP idiopathique treated(handled) initially 6 months by anti-vitamin K.

Enrollment

235 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients having ended the study PADIS EP after the visit of the end of study and having signed the consent HTP.

Exclusion criteria

  • Refusal to grant in writing to participate in the study PADIS HTP

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

235 participants in 1 patient group

HTPPE
Other group
Description:
No drug and no placebo were used in this study. For all the patients who participated at the study PADIS-EP, somme exams must be performed.
Treatment:
Other: HTPPE

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems